SCHEMBL6982390

SCHEMBL6982390

O=C(O)C1(CCc2ccccc2)OCC(c2ccccc2)(c2ccccc2)CO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
OPRM1 P35372 2/20 0.38
OPRL1 P41146 2/20 0.38
HSD11B1 P28845 1/20 0.38
KEAP1 Q14145 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
HDAC3 O15379 1/20 0.35
MAPK1 P28482 1/20 0.35
ADRA1A P35348 1/20 0.35
HDAC4 P56524 1/20 0.35
SLC6A3 Q01959 1/20 0.35
HDAC1 Q13547 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981777 0.72 AKR1C1 (0.41) ALDH1A1OPRM1OPRL1MEN1KMT2A
SCHEMBL6982070 0.70 AKR1C1 (0.40) ALDH1A1OPRM1OPRL1MEN1KMT2A
SCHEMBL11825227 0.70 OPRM1 (0.42) ALDH1A1OPRM1OPRL1MEN1KMT2A
SCHEMBL11209541 0.68 HDAC3 (0.47) ALDH1A1HSD11B1KEAP1HDAC3MAPK1
SCHEMBL13082818 0.68 OPRM1 (0.44) ALDH1A1OPRM1OPRL1HSD11B1KEAP1
SCHEMBL7269135 0.67 KDM1A (0.43) ALDH1A1SMN1; SMN2
SCHEMBL6982378 0.67 ALDH1A1 (0.40) ALDH1A1OPRM1OPRL1MEN1KMT2A
SCHEMBL21826552 0.66 KEAP1 (0.47) ALDH1A1OPRM1OPRL1HSD11B1KEAP1
SCHEMBL11203828 0.66 MAPT (0.50) HDAC3MAPK1ADRA1AHDAC4SLC6A3
SCHEMBL10487154 0.65 MAOA (0.39) ALDH1A1OPRM1OPRL1HSD11B1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed